Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

The Second Affiliated Hospital of Nanjing Medical University | China

Dr. Xiaofeng Shi is a Chinese medical professional and researcher with a strong academic background in medicine and hematology. He earned his Bachelor’s degree from Jiangsu University, followed by a Master’s degree from the School of Medicine at Suzhou University. He later completed his doctoral studies in the Department of Hematology at Shanghai Jiao Tong University School of Medicine. His academic training reflects a focused expertise in medical sciences, particularly in the field of hematology, contributing to clinical research and healthcare advancement.

Citation Metrics (Scopus)

600450

300

150

0

Citations
563
Documents
51
h-index
10

VIEW SCOPUS PROFILE

Featured Publications


Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

– American Journal of Hematology, 2025

Nomogram for predicting the 30- and 90-day prognoses of hemophagocytic lymphohistiocytosis patients: a multicenter and retrospective study

– Annals of Hematology, 2025

Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels

– Scientific Reports, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNS)

– Review, 2025

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes

– Review, 2025

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

University of Bari Aldo Moro | Italy

Prof. Fabio Sallustio is an Associate Professor in Applied Medical Technical Science at the University of Bari “Aldo Moro,” where he conducts advanced research in renal biology and kidney diseases. His work primarily focuses on the genomic and functional characterization of adult renal stem/progenitor cells and their role in kidney repair, as well as the cellular and molecular mechanisms underlying kidney disorders, particularly IgA nephropathy. He has made significant contributions to understanding how renal progenitor cells activate reparative processes, including identifying key pathways such as Toll-like receptor 2–mediated signaling and their role in tissue regeneration, fibrosis prevention, and immunomodulation. In parallel, his research on IgA nephropathy has advanced knowledge of disease pathogenesis through the identification of dysregulated molecular pathways, epigenetic alterations, and genetic variations. He leads a multidisciplinary research team and actively supervises students and doctoral researchers in the fields of medical biotechnology and molecular medicine.

Citation Metrics (Scopus)

30002000

1000

500

0

Citations
2,697
Documents
96
h-index
32

VIEW SCOPUS PROFILE
 VIEW Orcid PROFILE
 VIEW Google Scholar PROFILE

Featured Publications

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Université Paris Cité | France

Prof. Bruno Megarbane is a Professor at Université Paris Cité and serves as Head of the Department of Medical and Toxicological Critical Care at Lariboisière University Hospital. He is also a research team leader within the experimental research group at INSERM UMRS-1144. In addition, he acts as the medical head of the regional and national reference centre for chemicals, toxins, and toxicants (CORTOX), contributing to national health preparedness under the French General Direction of Health. His work primarily focuses on clinical toxicology, including drug poisoning, substance abuse, and envenomation.

Citation Metrics (Google Scholar)

40,00030,000

20,000

10,000

0

Citations

35,281

i10-index

402

h-index

90

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile
 View PubMed Profile

Featured Publications


A communication strategy and brochure for relatives of patients dying in the ICU

– New England Journal of Medicine, 2007 (Cited by 1743)

High versus low blood-pressure target in patients with septic shock

– New England Journal of Medicine, 2014 (Cited by 1474)

Initiation strategies for renal-replacement therapy in the intensive care unit

– New England Journal of Medicine, 2016 (Cited by 1415)

Hydrocortisone plus fludrocortisone for adults with septic shock

– New England Journal of Medicine, 2018 (Cited by 1038)